Next step, the Apple iPharm?
This article was originally published in Scrip
Executive Summary
Apple Inc, which on 20 July surpassed Microsoft's 1999 mark to become the most valuable publicly quoted corporation in history with a market capitalisation of $623.5 billion, is a business so unlike anything in the pharmaceutical sphere that cross-sectoral lessons can only be learned by contrast.